Search

everythinglearnresearchcommunity

for

Search:↓

HGF/SF injections can stimulate hair growth and increase hair follicle size in mice.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Mast cell and nerve fiber interactions in mouse skin change with the hair cycle.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

BMP4 helps stem cells turn into pigment-producing cells, affecting hair color and growth.

Hair shaft miR-221 levels can help detect malignant melanoma.

miR-182 may help treat hallux valgus by targeting FGF9.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Human hair follicles have a natural biomagnetic field.

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

A manufacturing error in a dietary supplement caused severe selenium poisoning, affecting many people and highlighting the need for stricter quality control.

Platelet-rich plasma injections significantly improved hair regrowth and thickness in patients with hair loss.

Systemic sclerosis skin shows varied gene patterns, suggesting potential for personalized treatment.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

Post-COVID conditions increase health care needs for six months after infection.

No single treatment is clearly effective for central serous chorioretinopathy.

Alopecia areata and its severe forms are becoming more common, especially among females, adults, and people in the Northeast.

Alopecia areata affects many in the US, impacting quality of life, with limited treatment options.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

People often have negative attitudes toward those with alopecia, especially if it's severe or seen as a medical issue.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Pomegranate leaves can be a cost-effective source of beneficial ingredients for health and skincare products.